Rinucumab Chemical Properties

form 

Liquid

color 

Colorless to light yellow

Rinucumab Usage And Synthesis

Uses

Rinucumab (REGN 2176), a monoclonal antibody, is a PDGF inhibitor. Rinucumab (REGN 2176) could be used for the study of neovascular age-related macular degeneration[1].

References

[1] Megan Cully, et al. Deal watch: Novartis eyes vision-enhancing therapy for macular degeneration. Nat Rev Drug Discov. 2014 Jul;13(7):487. DOI:10.1038/nrd4375

Rinucumab(1569263-06-4)Related Product Information

• Cendakimab
• Bertilimumab
• Tesnatilimab
• Ivicentamab
• Depatuxizumab
• Ulenistamab
• Pavunalimab
• Siplizumab
• Sotevtamab
• Lorvotuzumab Mertansine